Navigation Links
Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors
Date:3/11/2008

Appointment broadens reach of expanding care and care management company

BRENTWOOD, Tenn., March 11 /PRNewswire-USNewswire/ -- INSPIRIS, the Brentwood, Tenn.-based provider of care management for the frail elderly, announced today that well-known economist and health care policy expert Stuart Altman has been appointed to its board of directors.

INSPIRIS is an expert care and care management company focused on improving the quality of life for the frail elderly, the chronically ill and those with disabilities, while reducing the cost to Medicare Advantage, Medicaid and commercial health plans.

Altman comes to the INSPIRIS Board of Directors following a period of rapid growth and service expansion. In 2007, INSPIRIS added seven new service line contracts and began operations in the North/Central Florida Daytona and Philadelphia markets. INSPIRIS now meets the care and care management needs of qualifying members on behalf of multiple Medicare and Medicaid health plans representing more than 400,000 senior members in six states.

Altman is dean of The Heller School for Social Policy & Management and Sol C. Chaikin Professor of National Health Policy at Brandeis University. He has both a master's degree and doctorate in economics from the University of California, Los Angeles, and taught at Brown University and the Graduate School of Public Policy at the University of California at Berkeley.

"It is an honor to have an individual of Dr. Altman's stature and experience on the board of INSPIRIS," said Mike Tudeen, INSPIRIS' president and chief executive officer. "Dr. Altman has worked to help shape system reforms within Medicare and has long been a respected health care policy leader. We look forward to his significant contribution and oversight as he serves on INSPIRIS's Board of Directors."

A prolific writer of books and journal articles on health care payment systems and economic policy, Altman was listed in 200
'/>"/>

SOURCE INSPIRIS
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Stuart Collins Joins OrthoSynetics(TM) as Director, Eastern Region Sales
2. KePRO Names Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director
3. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
4. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
5. Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
6. Clarient Names Michele Hibbard, Ph.D. Director of Genetics
7. Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D.
8. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
9. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
10. Richard Greco Joins Mediware Board
11. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Evolution of the appendix 3A A biological remnant no more 9645 1Evolution of the appendix 3A A biological remnant no more 9645 2Evolution of the appendix 3A A biological remnant no more 9645 3Georgia Reproductive Specialists Free Infertility Seminar 3A Fertility Options 101 54991 1Naren Mallakunta Joins LAXAI 13639 1Naren Mallakunta Joins LAXAI 13639 2